SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-085058
Filing Date
2024-07-22
Accepted
2024-07-22 08:30:15
Documents
11
Period of Report
2024-07-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K atyr-20240722.htm   iXBRL 8-K 44885
  Complete submission text file 0000950170-24-085058.txt   161332

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atyr-20240722.xsd EX-101.SCH 27023
13 EXTRACTED XBRL INSTANCE DOCUMENT atyr-20240722_htm.xml XML 4710
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 241129581
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)